Quantitative multiparametric MRI of ovarian cancer

Journal of Magnetic Resonance Imaging

Volumn 38, Issue 6, 2013, Pages 1501-1509

  Carter, Jori S ^a   Koopmeiners, Joseph S ^a   Kuehn Hajder, Jessica E ^a   Metzger, Gregory J ^b   Lakkadi, Navneeth ^b   Downs Jr , Levi S ^a   Bolan, Patrick J ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

investigative techniques; magnetic resonance imaging; methods; neoplasms; ovary

Indexed keywords

CONTRAST MEDIUM;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; HISTOGRAM; HUMAN; IMAGE ANALYSIS; INFANT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PRIORITY JOURNAL;

INVESTIGATIVE TECHNIQUES; MAGNETIC RESONANCE IMAGING; METHODS; NEOPLASMS; OVARY;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIMODAL IMAGING; OVARIAN NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84890023579     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24119     Document Type: Article

References (29)

1. American Cancer Society. Cancer facts and figures 2009. Atlanta: American Cancer Society, 2009.
2. Munkarah A, Chatterjee M, Tainsky M,. Update on ovarian cancer screening. Curr Opin Obstet Gynecol 2007; 19: 22-26.
3. Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009; 10: 327-340.
4. Buy JN, Ghossain MA, Hugol D, et al. Characterization of adnexal masses: combination of color Doppler and conventional sonography compared with spectral Doppler analysis alone and conventional sonography alone. Am J Roentgenol 1996; 166: 385-393.
5. Stein SM, Laifer-Narin S, Johnson MB, et al. Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography. Am J Roentgenol 1995; 164: 381-386.
6. Levine D, Feldstein VA, Babcock CJ, Filly RA,. Sonography of ovarian masses: poor sensitivity of resistive index for identifying malignant lesions. Am J Roentgenol 1994; 162: 1355-1359.
7. Rehn M, Lohmann K, Rempen A,. Transvaginal ultrasonography of pelvic masses: evaluation of B-mode technique and Doppler ultrasonography. Am J Obstet Gynecol 1996; 175: 97-104.
8. Buys SS, Partridge E, Greene MH, et al. PLCO Project Team. Ovarian cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial; findings from the intial screen of a randomized trial. Am J Obstet Gynecol 2005; 193: 1630-1639.
9. Buys SS, Partridge E, Black A, et al. for the PLCO Project Team. Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial. JAMA 2011; 305: 2295-2303.
10. van Nagell JR, DePriest PD, Ueland FR, et al. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer 2007; 109: 1887-1896.
11. Booth SJ, Turnbull LW, Poole DR, Richmond I,. The accurate staging of cancer using 3T magnetic resonance imaging-a realistic option. BJOG 2008; 115: 894-901.
12. Hricak H, Chen M, Coakley FV, et al. Complex adnexal masses: detection and characterization with MR imaging-multivariate analysis. Radiology 2000; 214: 39-46.
13. Sohaib SA, Sahdev A, Van Trappen P, Jacobs IJ, Reznek RH,. Characterization of adnexal mass lesions on MR imaging. Am J Roentgenol 2003; 180: 1297-1304.
14. Thomassin-Naggara I, Toussaint I, Perrot N, et al. Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging. Radiology 2011; 258: 793-803.
15. Thomassin-Naggara I, Darai E, Cuenod CA, Rouzier R, Callard P, Bazot M,. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging 2008; 28: 111-120.
16. Thomassin-Naggara I, Bazot M, Daraï E, Callard P, Thomassin J, Cuenod CA,. Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. Radiology 2008; 248: 148-159.
17. Moteki T, Ishizaka H,. Diffusion-weighted EPI of cystic ovarian lesions: evaluation of cystic contents using apparent diffusion coefficients. J Magn Reson Imaging 2000; 12: 1014-1019.
18. Thomassin-Naggara I, Darai E, Cuenod CA, et al. Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol 2009; 19: 1544-1552.
19. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M,. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1998; 168: 497-505.
20. Guo JY, Reddick WE, Rosen MA, Song HK,. Dynamic contrast-enhanced magnetic resonance imaging parameters independent of baseline T10 values. Magn Reson Imaging 2009; 27: 1208-1215.
21. Parker GJ, Roberts C, Macdonald A, et al. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006; 56: 993-1000.
22. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-232.
23. OsiriX Imaging Software: Advanced Open-Source PACS Workstation DICOM Viewer. OsiriX Website. http://www.osirix-viewer.com. Accessed March 30, 2012.
24. R Project. R Version 2.14.2012-03-14. R Project Website. http://cran.r-project.org/doc/FAQ/R-FAQ.html. ISBN 3-900051-08-9. Accessed March 30, 2012.
25. Fujii S, Kakite S, Nishihara K, et al. Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions. J Magn Reson Imaging 2008; 28: 1149-1156.
26. Katayama M, Masui T, Kobayashi S, et al. Diffusion-weighted echo planar imaging of ovarian tumors: is it useful to measure apparent diffusion coefficients? J Comp Assist Tomogr 2002; 26: 250-256.
27. Kyriazi S, Collins DJ, Messiou C, et al. Metastatic ovarian and peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging-value of histogram analysis of apparent diffusion coefficients. Radiology 2011; 261: 182-192.
28. Nakayama T, Yoshimitsu K, Irie H, et al. Diffusion-weighted echo-planar MR imaging and ADC mapping in the differential diagnosis of ovarian cystic masses: usefulness of detecting keratinoid substances in mature cystic teratomas. J Magn Reson Imaging 2005; 22: 271-278.
29. Namimoto T, Awai K, Nakaura T, Yanaga Y, Hirai T, Yamashita Y,. Role of diffusion-weighted imaging in the diagnosis of gynecological diseases. Eur Radiol 2009; 19: 745-760.